These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7484777)

  • 21. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
    Raviele A; Brignole M; Sutton R; Alboni P; Giani P; Menozzi C; Moya A
    Circulation; 1999 Mar; 99(11):1452-7. PubMed ID: 10086969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A multicenter study on treatment of autonomous nerve-mediated syncope in children with beta-receptor blocker].
    Chen L; DU JB; Zhang QY; Wang C; DU ZD; Wang HW; Tian H; Chen JJ; Wang YL; Hu XF; Li WZ; Han L
    Zhonghua Er Ke Za Zhi; 2007 Dec; 45(12):885-8. PubMed ID: 18339272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of pindolol for treatment of vasovagal syncope.
    Cohen MB; Snow JS; Grasso V; Lehnert L; Goldner BG; Jadonath RL; Cohen TJ
    Am Heart J; 1995 Oct; 130(4):786-90. PubMed ID: 7572587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between isoproterenol and nitroglycerin sensitized head-upright tilt in patients with unexplained syncope and negative or positive passive head-up tilt response.
    Delépine S; Prunier F; Lefthériotis G; Dupuis J; Vielle B; Geslin P; Victor J
    Am J Cardiol; 2002 Sep; 90(5):488-91. PubMed ID: 12208407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes].
    Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP
    Ter Arkh; 2006; 78(4):64-8. PubMed ID: 16821426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of tertatolol. A comparative study versus atenolol.
    Mota JC; Carrageta MD; Felix S; Nunes AM; Jobbé-Duval M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):284S-288S. PubMed ID: 2573377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tilt-induced vasovagal syncope].
    Aarøe J; Hansen JB
    Ugeskr Laeger; 1994 Feb; 156(6):819-20. PubMed ID: 8016987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope.
    Lafuente EA; Martínez LC; Moguel JO; David RN; García JD; Tejeda AO; Reyes PH; González VR
    Arch Med Res; 2004; 35(5):416-20. PubMed ID: 15610912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
    Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
    J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test.
    Sheldon R; Rose S; Flanagan P; Koshman ML; Killam S
    Am J Cardiol; 1996 Sep; 78(5):536-9. PubMed ID: 8806338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of the tilt-table test in the management of unexplained syncope in children and adolescents].
    Kouakam C; Vaksmann G; Lacroix D; Godart F; Kacet S; Rey C
    Arch Mal Coeur Vaiss; 1997 May; 90(5):679-86. PubMed ID: 9295951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
    Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
    Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study.
    Palmisano P; Dell'Era G; Russo V; Zaccaria M; Mangia R; Bortnik M; De Vecchi F; Giubertoni A; Patti F; Magnani A; Nigro G; Rago A; Occhetta E; Accogli M
    Europace; 2018 May; 20(5):859-866. PubMed ID: 28407148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
    Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
    Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.